Tag Archives: $VRTX

Targeted Protein Degradation Comes of Age
May 15, 2019

This blog was written by Nello Mainolfi, CSO and co-founder of Kymera Therapeutics, as part of the From The Trenches feature of LifeSciVC. Translation of well validated biology into therapeutics remains one of the biggest challenges of modern drug development,

Leave a comment